Literature DB >> 8149575

Keratoconjunctivitis sicca in female patients infected with human immunodeficiency virus.

J A Lucca1, J S Kung, R L Farris.   

Abstract

We recently reported keratoconjunctivitis sicca (KCS) occurring as a single entity in approximately 20% of male patients testing positive for human immunodeficiency virus (HIV). In a subsequent study of HIV-positive females (n = 59; age range: 23 to 42 years), ten were found to have clinical signs and symptoms of KCS. The Schirmer test without anesthetic was performed on these patients, as well as on ten HIV negative females in the same age range. Reported as mean +/- 1 standard deviation, the result of the Schirmer test was 5.6 +/- 4.1 mm of wetting in the HIV-positive group, and 15.6 +/- 7.8 mm of wetting in the control group. The mean tear osmolarity test value of the HIV-positive patients was 318.8 +/- 9.5 mOsm/L, with 18 of the 20 suspect eyes testing positive for KCS. The tear osmolarity value among the female control patients was 304.1 +/- 5.9 mOsm/L, with one of the 20 eyes testing positive for KCS. We conclude from the data that KCS occurs at a significantly greater rate in HIV positive females than in the general population.

Entities:  

Mesh:

Year:  1994        PMID: 8149575

Source DB:  PubMed          Journal:  CLAO J        ISSN: 0733-8902


  3 in total

1.  Anterior segment and external ocular disorders associated with HIV infections in the era of HAART in Chiang Mai University Hospital, a prospective descriptive cross sectional study.

Authors:  Tassapol Singalavanija; Somsanguan Ausayakhun; Chulaluck Tangmonkongvoragul
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

2.  Ocular Manifestations of Acquired Immunodeficiency Syndrome.

Authors:  Young Shin Kim; Hae Jung Sun; Tae Hyong Kim; Kui Dong Kang; Sung Jin Lee
Journal:  Korean J Ophthalmol       Date:  2015-07-21

Review 3.  Human immunodeficiency virus and its effects on the visual system.

Authors:  Michael W Stewart
Journal:  Infect Dis Rep       Date:  2012-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.